β-Blocker–Induced Complications and the Patient With Glaucoma
- 9 February 1998
- journal article
- review article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 158 (3) , 221-226
- https://doi.org/10.1001/archinte.158.3.221
Abstract
Review from JAMA Internal Medicine — β-Blocker–Induced Complications and the Patient With Glaucoma — Newer Treatments to Help Reduce Systemic Adverse EventsThis publication has 34 references indexed in Scilit:
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research GroupPublished by American Medical Association (AMA) ,1996
- Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye SurveyPublished by American Medical Association (AMA) ,1991
- A Sensitive Radioligand Binding Assay for Timolol in PlasmaJournal of Pharmaceutical Sciences, 1991
- SYSTEMIC ADVERSE REACTIONS TO GLAUCOMA MEDICATIONSInternational Ophthalmology Clinics, 1989
- COMPARISON OF PLASMA BETA BLOCKING ACTIVITY OF BETAXOLOL AND TIMOLOLInternational Ophthalmology Clinics, 1989
- Congestive Heart Failure From BetaxololArchives of Ophthalmology (1950), 1987
- Adverse Respiratory and Cardiovascular Events Attributed to Timolol Ophthalmic Solution, 1978–1985American Journal of Ophthalmology, 1986
- The Mechanism of Timolol in Lowering Intraocular PressureArchives of Ophthalmology (1950), 1978
- Bedford glaucoma survey.BMJ, 1968